These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22205381)

  • 1. The clinical significance of anti-cyclic citrullinated peptide antibody in primary Sjögren syndrome.
    Kim SM; Park E; Lee JH; Lee SH; Kim HR
    Rheumatol Int; 2012 Dec; 32(12):3963-7. PubMed ID: 22205381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.
    Ryu YS; Park SH; Lee J; Kwok SK; Ju JH; Kim HY; Jeon CH
    Rheumatol Int; 2013 Jun; 33(6):1443-6. PubMed ID: 23179261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
    Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
    Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
    Atzeni F; Sarzi-Puttini P; Lama N; Bonacci E; Bobbio-Pallavicini F; Montecucco C; Caporali R
    Arthritis Res Ther; 2008; 10(3):R51. PubMed ID: 18462485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
    Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
    Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
    Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
    Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.
    Sène D; Ghillani-Dalbin P; Limal N; Thibault V; van Boekel T; Piette JC; Cacoub P
    Ann Rheum Dis; 2006 Mar; 65(3):394-7. PubMed ID: 16474032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
    Haga HJ; Andersen DT; Peen E
    Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image analysis of fibrosis in labial salivary glands of patients with systemic autoimmune diseases. Close correlation of lobular fibrosis to seropositive rheumatoid arthritis and increased anti-CCP and RF titres in the serum.
    Katona K; Farkas N; Kneif M; SütŐ G; Berki T; Balatonyi B; Tornóczky T
    Pathology; 2018 Jun; 50(4):418-425. PubMed ID: 29735168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
    Us D; Gülmez D; Hasçelik G
    Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
    Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
    J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
    Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
    Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.
    Chang PY; Yang CT; Cheng CH; Yu KH
    Int J Rheum Dis; 2016 Sep; 19(9):880-6. PubMed ID: 25940989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis.
    Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA
    J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
    Zhao Y; Li J; Li XX; Li C; Li L; Li ZG
    Joint Bone Spine; 2009 Oct; 76(5):501-7. PubMed ID: 19289297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C; Zofotă S; Bojincă V; Ionescu R
    Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.